Licensed Dealers for Controlled Drugs and Narcotics (Veterinary Use) Fees Regulations

Marginal note:Reduction granted — no revenue in previous fiscal year

• 9 (1) Despite subsection 8(1) and subject to subsection (2), where an applicant does not have any revenue referred to in subsection 8(1) for the applicant’s previous fiscal year, the Minister of Health shall grant an application for a fee reduction after the time limit referred to in subsection (2) if the total fee payable is more than 1.5 per cent of the applicant’s gross revenue from the sale, testing and packaging/labelling of controlled drugs and narcotics for the applicant’s fiscal year in which the application is made.

• Marginal note:Financial records

  (2) The revenue for the applicant’s fiscal year in which the application for a fee reduction is made shall be based on financial records prepared in accordance with generally accepted accounting principles and provided by the applicant within 90 days after the end of that fiscal year.

• Marginal note:Fees

  (3) Subject to subsection (4), the fee payable by an applicant referred to in subsection (1) is the total of:

  • (a) $875, payable on submission of the application for a fee reduction, and

  • (b) an amount equal to the difference between the following, payable within 90 days after the end of the applicant’s fiscal year in which the application is made,

    • (i) 1.5 per cent of the applicant’s gross revenue from sales, testing and packaging/labelling of controlled drugs and narcotics for the applicant’s fiscal year in which the application is made, and

    • (ii) the amount set out in paragraph (a).

• Marginal note:Remission

  (4) If the amount paid by an applicant in accordance with paragraph (3)(a) is greater than the amount payable under paragraph (3)(b), the Minister of Health shall grant a remission to the applicant of an amount equal to the difference between those amounts.

• Marginal note:Where  application refused

  (5) If the Minister of Health refuses to grant an application for a fee reduction pursuant to subsection (1) because the applicant fails to provide financial records within the period referred to in subsection (2) or because the total fee payable pursuant to section 3, 4 or 5 is not more than 1.5 per cent of the applicant’s gross revenue from the sale, testing and packaging/labelling of controlled drugs and narcotics for the applicant’s fiscal year in which the application is made, the fee payable by the applicant is an amount equal to the difference between

  • (a) the total fee payable pursuant to section 3, 4 or 5, and

  • (b) the amount paid by the applicant pursuant to paragraph (3)(a).

• Marginal note:Time of payment

  (6) The fee referred to in subsection (5) is payable upon the expiry of the 90 day period referred in subsection (2).